You are both absolutely right. I overstated the overlap between these two purposes of the "other support" information. John John R. Baumann, Ph.D. Director Office of Sponsored Programs & Research Support University of Missouri -- Kansas City 5100 Rockhill Road (US Postal Service) 5211 Rockhill Road (Express Delivery) Kansas City, MO 64110 816.235.1303 (v) 816.235.6532 (f) xxxxxx@umkc.edu -----Original Message----- From: Aull, Robert [mailto:xxxxxx@IUPUI.EDU] Sent: Friday, November 01, 2002 1:50 PM To: xxxxxx@HRINET.ORG Subject: Re: [RESADM-L] Other Support disclosures: Biosketch form vs. Other Support form I agree, they serve different purposes and equating the 'new' biosketch section C with Other Support makes the two seem particularly redundant to investigators. As an aside, the size limit of the biosketch has not really changed. Sections A and B (the traditional biosketch information) are still limited to two pages; the 'new' Section C adds a maximum of two pages more. No net gain in the list of publications. Robert Aull ERA Grants Mgr IUSM-Office of Operations 1120 South Drive FH 207 Indianapolis, IN 46202-5114 Voice: (317) 274-2325 Fax: (317) 278-6842 E-mail: xxxxxx@iupui.edu -----Original Message----- From: Charlie Hathaway [mailto:xxxxxx@AECOM.YU.EDU] Sent: Friday, November 01, 2002 2:21 PM To: xxxxxx@HRINET.ORG Subject: Re: [RESADM-L] Other Support disclosures: Biosketch form vs. Other Support form I disagree with some of John's answers... Listing of funding on the NIH biosketch is for review purposes only. The PI need only list those SELECTED projects, funded or not funded, during the last 3 years, that are relevant to the proposal. They may be grants that have ended. It does not include pending applications. Direct costs and % effort are not included. This should be completed strategically but truthfully to enhance competitiveness. If your proposal is on retinopathies in diabetics and you have another grant on some unrelated neuro thing, I would not include it unless it somehow promoted reviewers confidence in you as a efficient user of federal research investment. Other Support is an administrative issue. Reviewers will not see it as it is submitted after peer review. It must be comprehensive and complete, and include $$ and % effort. It must include pending applications but does not include funding that is not current. While the biosketch may contain unfunded projects (important to junior clinical people with only modest research experience), the formal Other Support only lists sources of all funds. Charlie At 12:36 PM 11/1/02 -0600, you wrote: >1. yes >2. Just the biosketch >3. not really >4. no > >John > >John R. Baumann, Ph.D. >Director >Office of Sponsored Programs & Research Support >University of Missouri -- Kansas City >5100 Rockhill Road (US Postal Service) >5211 Rockhill Road (Express Delivery) >Kansas City, MO 64110 > >816.235.1303 (v) >816.235.6532 (f) >xxxxxx@umkc.edu > > > > >-----Original Message----- >From: Kaufman, Patrick [mailto:xxxxxx@STOWERS-INSTITUTE.ORG] >Sent: Friday, November 01, 2002 12:21 PM >To: xxxxxx@HRINET.ORG >Subject: [RESADM-L] Other Support disclosures: Biosketch form vs. Other >Support form > > >It seems as if there are two different forms on the PHS 398 in which a >PI discloses other support sources: The Biosketch form and the Other >Support form. Can anybody briefly explain to me the differences >between disclosures on this form? I know that the biosketch is >included on all applications and the Other Support form is only >requested later for apps likely to get funded. Otherwise: > >1) are the same projects to be shown on both? > >2) does the study section see both? Or just the biosketch? > >3) are there different angles a researcher should take between the two >forms to help increase the likelihood of being funded (while still >being in compliance)? > >4) Does modular vs. non-modular make any difference? > >Any learnings would be helpful. > >Thanks, Pat > >Pat Kaufman >Director of Accounting & Grants Admin. >Stowers Institute for Medical Research >Kansas City, MO >816-926-4027 xxxxxx@stowers-institute.org > > >====================================================================== > Instructions on how to use the RESADM-L Mailing List, including >subscription information and a web-searchable archive, are available >via our web site at http://www.hrinet.org (click on "Listserv Lists") >====================================================================== > > >====================================================================== > Instructions on how to use the RESADM-L Mailing List, including >subscription information and a web-searchable archive, are available >via our web site at http://www.hrinet.org (click on "Listserv Lists") >====================================================================== > > ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================
